Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Published:2016-02-03 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Hyötyläinen Tuulia,Jerby Livnat,Petäjä Elina M.,Mattila Ismo,Jäntti Sirkku,Auvinen Petri,Gastaldelli Amalia,Yki-Järvinen Hannele,Ruppin Eytan,Orešič Matej

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9994.pdf

Reference50 articles.

1. Younossi, Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin. Gastroenterol. Hepatol. 9, 524–530 e521 quiz e560 (2011).

2. Van Gaal, L. F., Mertens, I. L. & De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880 (2006).

3. Cohen, J. C., Horton, J. D. & Hobbs, H. H. Human fatty liver disease: old questions and new insights. Science 332, 1519–1523 (2011).

4. Kotronen, A. & Yki-Jarvinen, H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 27–38 (2008).

5. Westerbacka, J. et al. Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology 139, 1961–1971 (2010).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel molecular pathway of lipid accumulation in human hepatocytes caused by PFOA and PFOS;Environment International;2024-09

2. Genome-scale metabolic network of human carotid plaque reveals the pivotal role of glutamine/glutamate metabolism in macrophage modulating plaque inflammation and vulnerability;Cardiovascular Diabetology;2024-07-08

3. High-resolution respirometry reveals altered mammalian tissue ketone body oxidation in different cardiometabolic diseases;2024-06-27

4. Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1;Frontiers in Pharmacology;2024-03-07

5. Hepatic glucose metabolism in the steatotic liver;Nature Reviews Gastroenterology & Hepatology;2024-02-02